243 related articles for article (PubMed ID: 19836233)
1. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Disubstituted indole acylsulfonamides: a novel series of potent and selective human EP3 receptor antagonists.
Zhou N; Zeller W; Krohn M; Anderson H; Zhang J; Onua E; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Jan; 19(1):123-6. PubMed ID: 19022669
[TBL] [Abstract][Full Text] [Related]
3. Peri-substituted hexahydro-indolones as novel, potent and selective human EP3 receptor antagonists.
O'Connell M; Zeller W; Burgeson J; Mishra RK; Ramirez J; Kiselyov AS; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Feb; 19(3):778-82. PubMed ID: 19121942
[TBL] [Abstract][Full Text] [Related]
4. 3-Acrylamide-4-aryloxyindoles: synthesis, biological evaluation and metabolic stability of potent and selective EP3 receptor antagonists.
Zhou N; Zeller W; Zhang J; Onua E; Kiselyov AS; Ramirez J; Palsdottir G; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Mar; 19(5):1528-31. PubMed ID: 19188065
[TBL] [Abstract][Full Text] [Related]
5. 1,7-Disubstituted oxyindoles are potent and selective EP(3) receptor antagonists.
Zhou N; Polozov AM; O'Connell M; Burgeson J; Yu P; Zeller W; Zhang J; Onua E; Ramirez J; Palsdottir GA; Halldorsdottir GV; Andresson T; Kiselyov AS; Gurney M; Singh J
Bioorg Med Chem Lett; 2010 Apr; 20(8):2658-64. PubMed ID: 20303752
[TBL] [Abstract][Full Text] [Related]
6. (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor.
Bell MG; Gernert DL; Grese TA; Belvo MD; Borromeo PS; Kelley SA; Kennedy JH; Kolis SP; Lander PA; Richey R; Sharp VS; Stephenson GA; Williams JD; Yu H; Zimmerman KM; Steinberg MI; Jadhav PK
J Med Chem; 2007 Dec; 50(26):6443-5. PubMed ID: 18038968
[TBL] [Abstract][Full Text] [Related]
7. Novel methylene-linked heterocyclic EP1 receptor antagonists.
Hall A; Bit RA; Brown SH; Chowdhury A; Giblin GM; Hurst DN; Kilford IR; Lewell X; Naylor A; Scoccitti T
Bioorg Med Chem Lett; 2008 Mar; 18(5):1592-7. PubMed ID: 18262416
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.
Asada M; Obitsu T; Kinoshita A; Nakai Y; Nagase T; Sugimoto I; Tanaka M; Takizawa H; Yoshikawa K; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem Lett; 2010 Apr; 20(8):2639-43. PubMed ID: 20346663
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.
Cole DC; Lennox WJ; Lombardi S; Ellingboe JW; Bernotas RC; Tawa GJ; Mazandarani H; Smith DL; Zhang G; Coupet J; Schechter LE
J Med Chem; 2005 Jan; 48(2):353-6. PubMed ID: 15658848
[TBL] [Abstract][Full Text] [Related]
13. Isoindolone derivatives, a new class of 5-HT2C antagonists: synthesis and biological evaluation.
Hamprecht D; Micheli F; Tedesco G; Checchia A; Donati D; Petrone M; Terreni S; Wood M
Bioorg Med Chem Lett; 2007 Jan; 17(2):428-33. PubMed ID: 17074479
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
[TBL] [Abstract][Full Text] [Related]
15. Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists.
Naganawa A; Matsui T; Ima M; Yoshida K; Tsuruta H; Yamamoto S; Yamamoto H; Okada H; Maruyama T; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Dec; 14(23):7774-89. PubMed ID: 16931028
[TBL] [Abstract][Full Text] [Related]
16. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
17. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.
Beaulieu C; Guay D; Wang Z; Leblanc Y; Roy P; Dufresne C; Zamboni R; Berthelette C; Day S; Tsou N; Denis D; Greig G; Mathieu MC; O'Neill G
Bioorg Med Chem Lett; 2008 Apr; 18(8):2696-700. PubMed ID: 18359630
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies leading to the identification of (2E)-3-[l-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methyl-lH-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041), a potent and selective prostanoid EP3 receptor antagonist, as a novel antiplatelet agent that does not prolong bleeding.
Singh J; Zeller W; Zhou N; Hategan G; Mishra RK; Polozov A; Yu P; Onua E; Zhang J; Ramírez JL; Sigthorsson G; Thorsteinnsdottir M; Kiselyov AS; Zembower DE; Andrésson T; Gurney ME
J Med Chem; 2010 Jan; 53(1):18-36. PubMed ID: 19957930
[TBL] [Abstract][Full Text] [Related]
19. Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists.
Hennessy EJ; Grewal G; Byth K; Kamhi VM; Li D; Lyne P; Oza V; Ronco L; Rooney MT; Saeh JC; Su Q
Bioorg Med Chem Lett; 2015; 25(10):2041-5. PubMed ID: 25890801
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiinflammatory activity of heterocyclic indole derivatives.
Rani P; Srivastava VK; Kumar A
Eur J Med Chem; 2004 May; 39(5):449-52. PubMed ID: 15110970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
